Abstract
The development of autoantibodies is observed in autoimmune disorders and numerous cancers. Consequently, autoantibodies form the basis of potential diagnostic and prognostic assays, as well as approaches for monitoring disease progression and treatment response. The effective use of autoantigen biomarkers for these applications, however, is contingent upon the identification of not one but multiple biomarkers. This is a consequence of the observation that the development of autoantibodies to any given protein is typically seen only in a fraction of patients. We have previously demonstrated the utility of functional protein microarrays containing thousands of different human proteins (ProtoArrays®) for discovering novel autoimmune biomarkers in serum and plasma. Here, we describe a protocol for detecting autoantibodies in urine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Arbuckle, M.R, McClain, M.T., Rubertone, M.V. et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med., 349, 1526–1533.
Disis, M.L., Montgomery, R.B., Goodell, V., delaRosa, C., and Salazar, L.G. (2005) Antibody Immunity to Cancer-Associated Proteins. AACR 96th Annual Meeting, April 16–20, 166–169.
Robinson, W.H., DiGennaro, C., Hueber, W. et al. (2002) Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med., 8, 295–301.
Robinson, W.H., Fontoura, P., Lee, B.J. et al. (2003) Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol., 21, 1033–1039.
Braun, P., Hu, Y., Shen, B. et al. (2002) Proteome-scale purification of human proteins from bacteria. Proc. Natl. Acad. Sci. U.S.A., 99, 2654–2659.
Lueking, A., Huber, O., Wirths, C. et al. (2005) Profiling of alopecia areata autoantigens based on protein microarray technology. Mol. Cell Proteomics, 4, 1382–1390.
Gutjahr, C., Murphy, D., Lueking, A. et al. (2005) Mouse protein arrays from a TH1 cell cDNA library for antibody screening and serum profiling. Genomics, 85, 285–296.
Chen Y.T., Scanlan, M.J., Sahin, U., Tureci, O., Gure, A.O., Tsang, S. et al. (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. U.S.A., 94, 1914–1918.
Sahin, U., Tureci, O., Schmitt, H., Cochlovius, B., Johannes, T., Schmits R. et al. (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. U.S.A., 92, 11810–11813.
Nam, M.J., Madoz-Gurpide, J., Wang, H., Lescure, P., Schmalbach, C.E., Zhao, R. et al. (2003) Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics, 3, 2108–2115.
Brichory, F.M., Misek, D.E., Yim, A.M., Krause, M.C., Giordano, T.J., Beer, D.G., and Hanash, S.M. (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl. Acad. Sci. U.S.A. 98, 9824–9829.
Zhu, H., Bilgin, M., Bangham, R. et al. (2001) Global analysis of protein activities using proteome chips. Science, 293, 2101–2105.
Predki, P.F., Mattoon, D., Bangham, R., Schweitzer, B., and Michaud, G. (2005) Protein microarrays: A new tool for profiling antibody cross-reactivity. Hum. Antibodies, 14, 7–15.
Hanson, L.A. and Tan, E.M. (1965) Characterization of antibodies in urine. J. Clin. Invest., 44, 703–715.
Stevens, M.B. and Knowles, B. (1962) Significance of urinary gamma globulin in lupus nephritis. N. Engl. J. Med., 267, 1159–1164.
Gambardella, S., Morano, S., Cancelli, A., Pietravalle, P., Frontoni, S., Bacci, S., Di Mario, U., and Andreani, D. (1989) Urinary IgG4: an additional parameter in characterizing patients with incipient diabetic nephropathy. Diabetes Res., 10, 153–157.
Bakoush, O., Segelmark, M., Torffvit, O., Ohlsoon, S., and Tencer, J. (2006) Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis. Nephrol. Dial. Transplant., 21, 1263–1269.
Huland, H., Otto, U., and Droese, M. (1983) The value of urinary cytology, serum and urinary carcinoembryonic antigen, rheumatoid factors, and urinary immunoglobulin concentration as tumor markers or prognostic factors in predicting progression of superficial bladder cancer. Eur. Urol., 9, 346–349.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Schweitzer, B., Meng, L., Mattoon, D., Rai, A.J. (2010). Immune Response Biomarker Profiling Application on ProtoArray® Protein Microarrays. In: Rai, A. (eds) The Urinary Proteome. Methods in Molecular Biology, vol 641. Humana Press. https://doi.org/10.1007/978-1-60761-711-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-60761-711-2_14
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-710-5
Online ISBN: 978-1-60761-711-2
eBook Packages: Springer Protocols